TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT04511793

Hepatic Artery Infusion (HAI) Program at Duke University

Cause of deathSlow enrollment, also funding or business Automatic label, confidence 0.5, unverified. How labels are made.
“No subjects enrolled due to availability of device commercially.”

The sponsor’s own words in the registry.

Life of this trial

202020212022Registered2020-08-11Planned start2020-12-11 (planned)Withdrawn (as of)2021-07-19

Vital statistics

Status
Withdrawn
Phase
Na
Sponsor
Michael Lidsky, M.D.
Sponsor type
University, hospital or other
Conditions
Metastatic Colon Cancer; Liver Cancer; Intrahepatic Cholangiocarcinoma
Interventions
Medtronic Synchromed II pump
Participants
0

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.